Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: A pilot study

Clinical Lung Cancer

Volumn 10, Issue 1, 2009, Pages 53-57

  Tibaldi, Carmelo ^a,c   Mazzoni, Enrica ^a   Arcabasso, Giandomenico ^a   D'Incecco, Armida ^a   Antonuzzo, Andrea ^a   Menconi, Gianfranco ^a   Falcone, Alfredo ^a,b  

^a ISTITUTO TOSCANO TUMORI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Presidio Ospedaliero   (Italy)

Author keywords

Cisplatin; Gemcitabine; Lobectomy; Neutropenia

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OTOTOXICITY; PATIENT COMPLIANCE; PILOT STUDY; THROMBOCYTOPENIA; THROMBOCYTOSIS;

EID: 62549094404     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2009.n.008     Document Type: Article

References (15)

1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24:4539-44.
2. Jemal A, Siegel R, Ward E, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
3. Pisters KM, Evans WK, Azzoli CG, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small-cell lung cancer guideline. J Clin Oncol 2007; 25:5506-18.
4. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-60.
5. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589-97.
6. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]: a randomized controlled trial. Lancet Oncol 2006; 7:719-27.
7. Scagliotti GV, De Marinis F, Rinaldi M, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002; 20:4285-91.
8. Martoni A, Marino A, Sperandi F, et al. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer 2005; 41:81-92.
9. National Cancer Institute. Cancer Therapy Evaluation Programs (CTEP) Common toxicity criteria-Version 2.0. Bethesda (MD) (1999): Division of Cancer Treatment and Diagnosis, National Cancer Institute. Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed: January 15, 2009.
10. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008; 26:3552-9.
11. Gebbia V, Galetta D, Lorusso V. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale). Lung Cancer 2008; 61:369-77.
12. Azzoli CG, Krug LM, Miller WA, et al. A phase II study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer. J Thoracic Oncol 2007; 2:638-44.
13. Strauss GM, Herndon J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer: Report of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2004; 22:14s (Abstract 7019).
14. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group (CALGB) protocol 9633. J Clin Oncol 2006; 24:365s (Abstract 7007).
15. Ardizzoni A, Boni L, Tiseo M, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 2007; 99:847-57.